drug

on

B Sample Test Update From AJ Allmendinger
July 24, 2012
Statement from Tara Ragan, Vice President, Walldinger Racing Inc.

Charlotte, NC (July 24, 2012)-

Aegis Analytical Laboratories in Nashville has delivered the results of the “B” sample test for Penske Racing driver AJ Allmendinger, which confirmed the results of the “A” test.

“This was not the news we wanted to hear and we will work to get to the source of what may have caused this. To that end, we have secured the services of an independent lab to conduct thorough testing on every product within AJ’s home and motor coach to find what might collaborate with his test, which created results that were within nanograms of accepted standards.

We are working closely with NASCAR and Penske Racing to identify the next action steps in this process. We continue to be extremely grateful by the breadth and scope of support for AJ from his fans and partners. We would like to again thank NASCAR, Penske Racing and all our sponsor partners for the open communication, and for helping us at every step in this process. We expect to have further updates in the upcoming days.”

-Tara Ragan, Vice President, Walldinger Racing Inc.

on

SHELL AND PENNZOIL STATEMENT:

Shell and Pennzoil believe that the process and procedures that NASCAR has in place as part of their substance abuse policy are appropriate and serve to ensure that the sport and its participants are held to the highest standards.

We share Penske Racing’s disappointment with the result of AJ’s (Allmendinger) B sample test and will work closely with them to determine plans moving forward. We hope for the best for AJ during this difficult time.

on

DAYTONA BEACH, Fla. (July 17, 2012) NASCAR has been informed by the NASCAR Substance Abuse Policy Program Administrator (Dr. David Black of Aegis Sciences Corporation) that the test of AJ Allmendinger’s “B” sample will take place on Tuesday, July 24. The test will be conducted in Nashville, Tennessee at Aegis headquarters, per the NASCAR rule book.

Review of timeline:

· On June 29, NASCAR member Allmendinger, driver of the #22 car in the NASCAR Sprint Cup Series, was randomly tested by Aegis at the NASCAR event in Kentucky, per Section 19-6C.

Continue reading “AJ Allmendinger’s B Sample Test Set for July 24th”

on

Penske Racing Statement on No. 22 Car at New Hampshire

“Penske Racing is continuing to work with NASCAR to follow its process and procedures related to the positive drug test that AJ Allmendinger was notified of this past weekend. While this process continues, Sam Hornish Jr. will drive the No. 22 car in this week’s Sprint Cup Series race at New Hampshire Motor Speedway.”